U.S. Global Investors (USGI)’s Elevance Health ELV Stock Holding History

U.S. Global Investors (USGI)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$64K	–	154
2020 Q4	$64K	Buy	+200	New	+$61.4K	﹤0.01%	164
2016 Q1	–	Sell	-2,600	Closed	-$363K	–	210
2015 Q4	$363K	Hold	2,600	–	–	0.19%	128
2015 Q3	$364K	Buy	2,600 +600	+30%	+$90.2K	0.19%	112
2015 Q2	$328K	Hold	2,000	–	–	0.13%	148
2015 Q1	$309K	Hold	2,000	–	–	0.09%	170
2014 Q4	$251K	Hold	2,000	–	–	0.07%	193
2014 Q3	$239K	Sell	2,000 -100	-5%	-$11.5K	0.07%	169
2014 Q2	$226K	Sell	2,100 -600	-22%	-$61.8K	0.05%	205
2014 Q1	$269K	Hold	2,700	–	–	0.04%	212
2013 Q4	$249K	Hold	2,700	–	–	0.04%	222
2013 Q3	$226K	Hold	2,700	–	–	0.04%	205
2013 Q2	$221K	Buy	+2,700	New	+$202K	0.04%	210

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Global Investors (USGI)'s ELV Position: Q1 2021 in Review

U.S. Global Investors (USGI) sold out of Elevance Health (ELV) in Q1 2021, closing a stake of 200 shares — an estimated $64K sold.

U.S. Global Investors (USGI) first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $364K in Q3 2015. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

U.S. Global Investors (USGI) reported no remaining Elevance Health position as of Q1 2021 after selling out during the quarter.
U.S. Global Investors (USGI) sold 200 Elevance Health shares in Q1 2021, an estimated $64K.
U.S. Global Investors (USGI) first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
U.S. Global Investors (USGI)'s Elevance Health position peaked at $364K in Q3 2015.
1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2021, filed 23 Apr 2021.